Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differences in Susceptibility to SARS CoV-2 Infection According to ACE2 and CD26 Receptors, Specific CD4/CD8 T Cell Response to Viral Peptides, and KIR Receptors Among Health Care Workers Highly Exposed to Patients With COVID-19 Diagnosis.

NCT04402827 is registered in ClinicalTrials.gov with Asociacion para el Estudio de las Enfermedades Infecciosas as lead sponsor.

NCT NCT04402827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04402827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differences in Susceptibility to SARS CoV-2 Infection According to ACE2 and CD26 Receptors, Specific CD4/CD8 T Cell Response to Viral Peptides, and KIR Receptors Among Health Care Workers Highly Exposed to Patients With COVID-19 Diagnosis.
Lead sponsor
Asociacion para el Estudio de las Enfermedades Infecciosas
Phase
Observational
Overall status
Completed
Start date
August 1, 2020
Completion date
September 30, 2021
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

health care worker patient transmission, immune response, receptor site alteration, susceptibility, disease